CEA (Carcinoembryonic Antigen)

CEA (Carcinoembryonic Antigen) is a cancer screening markers biomarker that Marker for certain cancers (colon The normal reference range is Tumor marker for colon and other GI cancers. Also elevated in smokers and inflammatory conditions. Used for cancer monitoring more than screening.. Regular testing helps track changes and identify potential health issues early.

2 out of 10 major blood testing providers include CEA (Carcinoembryonic Antigen) in their standard panels. These include Function, Marek Health.

For most people, testing CEA (Carcinoembryonic Antigen) 2-4 times per year is recommended to establish baseline levels and track trends. If you have abnormal results or are actively working to optimize this biomarker, more frequent testing (quarterly) may be beneficial. Always consult with your healthcare provider for personalized testing frequency recommendations.

The standard laboratory reference range for CEA (Carcinoembryonic Antigen) is Tumor marker for colon and other GI cancers. Also elevated in smokers and inflammatory conditions. Used for cancer monitoring more than screening.. However, many functional medicine practitioners recommend tighter "optimal" ranges for peak health and performance. Your ideal range may vary based on your age, sex, health goals, and other individual factors. Work with a healthcare provider familiar with optimal ranges to determine your target levels.

Most direct-to-consumer blood testing services that include CEA (Carcinoembryonic Antigen) provide the physician order as part of their service. However, some states have restrictions on direct-to-consumer testing. Check with your chosen provider about availability in your state and whether they provide the necessary physician authorization.

lung)